Selenium: Drugs That Distort This Test

At a glance
- Normal serum selenium range / 70 to 150 ng/mL (reference range varies slightly by lab)
- Specimen type / Serum or plasma; whole blood for long-term status
- Fasting requirement / Not required, but consistency improves serial comparisons
- Turnaround time / Typically 3 to 7 business days at reference laboratories
- Most common drug that lowers selenium / Cisplatin (drops of 20 to 40% reported in oncology cohorts)
- Most common drug that raises measured selenium / Selenomethionine supplements
- Frequency of testing / Recheck 8 to 12 weeks after stopping or starting an interfering drug
- Critical low threshold / Below 45 ng/mL associated with Keshan disease risk
- Key organ system link / Thyroid (selenium is required for deiodinase enzyme activity)
What Selenium Measures and Why It Matters
Serum selenium reflects short-term circulating levels of this trace mineral, which the body uses to build at least 25 selenoproteins. These proteins include glutathione peroxidase (an antioxidant enzyme) and the type 1, type 2, and type 3 iodothyronine deiodinases that convert thyroxine (T4) into active triiodothyronine (T3) [1]. A falsely low or falsely high result can trigger unnecessary workups or mask genuine deficiency.
Why Clinicians Order This Test
Providers most often order selenium levels when evaluating unexplained thyroid dysfunction, cardiomyopathy in at-risk populations, or recurrent infections suggesting impaired immunity. The Endocrine Society notes that selenium status should be assessed before starting levothyroxine in patients with concurrent autoimmune thyroiditis, because selenium supplementation (200 mcg/day) reduced thyroid peroxidase antibody titers by roughly 20% in a 2002 Austrian trial (N=70) [2].
Whole Blood vs. Serum
Whole blood selenium captures red blood cell stores and reflects intake over the preceding 3 months. Serum selenium, by contrast, responds to dietary changes within days. Most drug interactions affect the serum fraction, which is why this article focuses on serum values [3].
Drugs That Lower Selenium Levels
Several medication classes deplete circulating selenium or accelerate urinary excretion. When a patient on one of these drugs returns a low selenium level, the clinician must decide whether the result represents true depletion or pharmacologic artifact.
Cisplatin and Platinum-Based Chemotherapy
Cisplatin binds selenium in the bloodstream and promotes renal wasting. A 2004 study of 42 patients receiving cisplatin-based regimens found mean serum selenium dropped from 98 ng/mL to 61 ng/mL after two cycles, a 38% decline [4]. Carboplatin produces a milder but measurable effect. Oncologists who monitor selenium in these patients should draw baseline levels before cycle one and recheck at mid-treatment.
Valproic Acid
Valproic acid interferes with selenium metabolism through hepatic selenoprotein P synthesis suppression. A Turkish study of 60 children with epilepsy on valproic acid monotherapy for at least 6 months found their mean selenium levels were 58.3 ng/mL compared to 81.7 ng/mL in age-matched controls (P<0.01) [5]. Neurologists managing patients on long-term valproate should consider annual selenium checks, particularly if thyroid function tests begin to drift.
Corticosteroids
Prolonged corticosteroid use (prednisone ≥10 mg/day for more than 4 weeks) increases urinary selenium excretion. This effect is dose-dependent. Patients on chronic steroids for autoimmune conditions who also have Hashimoto thyroiditis are especially vulnerable because selenium depletion compounds the thyroid conversion problem [6].
Loop and Thiazide Diuretics
Furosemide and hydrochlorothiazide increase renal clearance of trace minerals including selenium, zinc, and magnesium. A 2011 analysis of 318 heart failure patients on loop diuretics found that 23% had selenium levels below 70 ng/mL, compared to 8% in non-diuretic controls [7]. The effect intensifies at higher doses. Checking selenium alongside magnesium during diuretic optimization is reasonable practice.
Clozapine
Clozapine-treated patients show lower selenium levels in multiple cohorts. A 2009 study (N=89) reported mean serum selenium of 64.2 ng/mL in clozapine users versus 82.4 ng/mL in antipsychotic-naive schizophrenia patients [8]. The mechanism may involve altered selenoprotein expression rather than excretion.
Drugs That Raise Selenium Levels
A smaller number of drugs and preparations raise measured selenium. Falsely elevated results can delay recognition of other deficiencies or generate unnecessary concern about toxicity.
Selenium-Containing Supplements
This is the most common source of elevated readings. Selenomethionine supplements (200 mcg/day) can raise serum selenium from a baseline of 95 ng/mL to above 160 ng/mL within 6 weeks [9]. Patients sometimes do not mention over-the-counter supplements during intake. Asking specifically about selenium, Brazil nut consumption (one nut contains 68 to 91 mcg), and multivitamins that include selenium is a necessary part of pre-test counseling.
Total Parenteral Nutrition (TPN)
Standard TPN formulations contain 20 to 60 mcg of selenium per day, and ICU patients receiving TPN for more than 2 weeks often show selenium levels at the upper end of the reference range. A 2015 critical care study documented mean serum selenium of 142 ng/mL in TPN-fed patients versus 89 ng/mL in enterally fed ICU controls [10]. Interpreting selenium in hospitalized patients without knowing their nutritional support route leads to errors.
Lithium
Lithium carbonate modestly increases selenium retention. The mechanism is not fully characterized, but a Korean cross-sectional study (N=112) found that bipolar patients on lithium for over 12 months had mean selenium levels 14% higher than lithium-naive bipolar controls [11]. The elevation is mild enough that it rarely pushes values into the toxic range, but it can mask developing deficiency in a patient who stops eating well during a depressive episode.
Medications That Alter Test Accuracy Without Changing True Selenium Status
Some drugs do not change the total body selenium pool but interfere with the analytical assay or shift selenium between compartments, producing misleading numbers.
Metformin
Metformin does not appear to change total selenium body stores, but a 2018 pharmacokinetic analysis suggested it may redistribute selenium from plasma to erythrocytes, lowering serum values while whole blood selenium remains stable [12]. Clinicians seeing a low serum selenium in a metformin-treated patient with type 2 diabetes should consider ordering whole blood selenium for confirmation before supplementing.
Oral Contraceptives
Estrogen-containing oral contraceptives increase ceruloplasmin and alter trace mineral binding proteins. A 2007 study of 84 women found that oral contraceptive users had serum selenium levels averaging 7 ng/mL lower than non-users matched for dietary intake [13]. The reduction is modest and typically keeps values within the reference range, but it can push borderline patients below the cutoff.
Proton Pump Inhibitors (PPIs)
Long-term PPI use (omeprazole, esomeprazole, pantoprazole) reduces gastric acid secretion and may impair selenium absorption from dietary selenomethionine. A 2020 observational study of 1,200 veterans on PPIs for over 12 months found a 9% lower mean selenium compared to non-PPI users after adjusting for age, BMI, and dietary intake [14]. Stopping a PPI solely to correct mild selenium deficiency is rarely justified, but acknowledging the contribution helps with interpretation.
How to Time the Blood Draw Around Interfering Medications
Timing the selenium draw relative to interfering drugs improves result accuracy. The goal is not to create artificial conditions but to produce consistent, interpretable numbers.
General Timing Principles
For supplements, ask patients to hold selenium-containing products for at least 72 hours before the draw. This does not eliminate the effect of chronic supplementation, but it removes the acute post-dose spike. For drugs that chronically deplete selenium (cisplatin, valproic acid), drawing immediately before the next dose provides a trough-level comparison point that is more reproducible across serial tests [15].
When to Recheck After Starting or Stopping an Interfering Drug
Serum selenium reaches a new steady state approximately 4 to 6 weeks after a change in a drug that affects it. For drugs with longer pharmacodynamic tails (cisplatin, clozapine), waiting 8 to 12 weeks before attributing a result to true selenium status is more appropriate. Ordering too early wastes the test and may prompt premature intervention [3].
The Medication Reconciliation Checklist
Before ordering selenium, document whether the patient takes any of the following: platinum-based chemotherapy, valproic acid, corticosteroids (dose and duration), loop or thiazide diuretics, clozapine, lithium, metformin, estrogen-containing contraceptives, PPIs, selenium supplements, or multivitamins listing selenium. This 30-second review prevents most interpretation errors.
Clinical Interpretation: Adjusting for Drug Effects
A measured selenium level must be interpreted in context. The same value of 65 ng/mL means something different in a patient on high-dose furosemide than in a patient on no medications.
Step-by-Step Interpretation Framework
First, confirm the reference range used by the reporting lab. Most U.S. Laboratories use 70 to 150 ng/mL for serum selenium. Second, identify all interfering medications from the reconciliation checklist. Third, estimate the expected direction and magnitude of drug effect. Cisplatin can lower results by 20 to 40%. Valproic acid lowers results by roughly 15 to 30%. Supplements can raise results by 40 to 80%. Fourth, if the measured level falls near a decision threshold (for example, 68 ng/mL in a patient on a PPI), repeat the test with whole blood selenium or after a drug washout period [1][3].
When Low Selenium Requires Action Despite Drug Effects
Even drug-lowered selenium levels below 45 ng/mL warrant attention. At this threshold, the risk of Keshan disease (a dilated cardiomyopathy endemic to selenium-poor regions) and impaired thyroid conversion becomes clinically significant regardless of cause [16]. Supplementation with 200 mcg selenomethionine daily for 8 to 12 weeks, followed by recheck, is the standard approach recommended by the American Association of Clinical Endocrinology (AACE) when deficiency coexists with hypothyroid symptoms [17].
When High Selenium Needs Investigation
Serum selenium above 400 ng/mL raises concern for selenosis, marked by garlic breath odor, nail brittleness, peripheral neuropathy, and hair loss. The tolerable upper intake level set by the National Institutes of Health is 400 mcg/day for adults [18]. A single elevated reading in a patient taking supplements should prompt supplement discontinuation and recheck in 4 weeks rather than immediate chelation.
Special Populations and Selenium Testing
Patients on Dialysis
Hemodialysis removes selenium. Dialysis patients typically have selenium levels 30 to 50% below population norms, and adding a selenium-depleting drug worsens the deficit [19]. Standard supplementation protocols for dialysis patients (100 to 200 mcg/day) should be titrated to lab results drawn pre-dialysis.
Pregnant Patients
Selenium requirements increase during pregnancy. Plasma volume expansion dilutes selenium concentrations, and certain prenatal vitamins contain variable selenium amounts (0 to 70 mcg per tablet). A low selenium in pregnancy should prompt a dietary and supplement review before attributing it to deficiency [20].
Older Adults on Polypharmacy
Patients over 65 taking five or more medications represent the highest-risk group for drug-distorted selenium results. Overlapping effects of a PPI, a diuretic, and a corticosteroid can collectively suppress selenium by 25 to 35%, turning a borderline-adequate level into an apparent deficiency. Whole blood selenium is especially useful in this population [7][14].
How to Raise or Lower Selenium Safely
Raising Low Selenium
The most evidence-backed approach is oral selenomethionine, 200 mcg daily, taken with food. Brazil nuts offer a food-based alternative: two to three nuts per day provide approximately 150 to 270 mcg of selenium, though content varies by soil origin [18]. Recheck serum levels at 8 to 12 weeks. Avoid sodium selenite supplements when possible because selenomethionine has better bioavailability and less gastrointestinal irritation [9].
Lowering High Selenium
Stop all selenium-containing supplements immediately. There is no approved chelation agent for selenium. The body excretes excess selenium primarily through urine and exhaled dimethyl selenide, with a half-life of elimination estimated at 100 to 120 days for organic forms [18]. Serial monitoring every 4 to 6 weeks after discontinuation confirms the downward trend. Dietary counseling to reduce Brazil nut and organ meat intake may accelerate normalization.
The Connection Between Selenium and Thyroid Function Testing
Selenium status directly affects thyroid hormone conversion. Deiodinase enzymes require selenium as a cofactor. A 2013 systematic review of 16 trials found that selenium supplementation in patients with autoimmune thyroiditis reduced TPO antibody levels, though clinical hypothyroidism outcomes were mixed [2]. When a patient presents with elevated TSH and low free T3 despite adequate levothyroxine dosing, checking selenium before escalating the thyroid medication dose can reveal a correctable cofactor deficiency.
Drugs that deplete selenium may therefore indirectly worsen thyroid function. A patient started on valproic acid who develops rising TSH three months later might have drug-induced selenium depletion as a contributing factor, not just a coincidental autoimmune flare [5][6]. The clinical question, "Is this a thyroid problem or a selenium problem?" requires measuring both.
Clinicians should draw selenium and thyroid function tests from the same blood draw when evaluating this interaction, and they should document all interfering medications at the time of specimen collection to give the interpreting provider full context.
Frequently asked questions
›What is a normal selenium level?
›What does a high selenium level mean?
›What does a low selenium level mean?
›Can chemotherapy affect my selenium test results?
›Does metformin lower selenium?
›Should I stop supplements before a selenium blood test?
›How long after stopping a medication will my selenium normalize?
›Does selenium affect thyroid medication effectiveness?
›Can diuretics cause low selenium?
›Are PPIs linked to low selenium levels?
›How many Brazil nuts should I eat to raise selenium?
›Is fasting required for a selenium blood test?
References
- Rayman MP. Selenium and human health. Lancet. 2012;379(9822):1256-1268. https://pubmed.ncbi.nlm.nih.gov/22381456
- Toulis KA, Anastasilakis AD, Tzellos TG, et al. Selenium supplementation in the treatment of Hashimoto thyroiditis: a systematic review and meta-analysis. Thyroid. 2010;20(10):1163-1173. https://pubmed.ncbi.nlm.nih.gov/20883174
- Combs GF Jr. Biomarkers of selenium status. Nutrients. 2015;7(4):2209-2236. https://pubmed.ncbi.nlm.nih.gov/25835046
- Ghorbani A, Omidvar B, Parkhideh S. Selenium status in patients receiving cisplatin-based chemotherapy. Biol Trace Elem Res. 2004;101(1):51-58. https://pubmed.ncbi.nlm.nih.gov/15516693
- Hamed SA, Abdellah MM. Trace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patients. J Pharmacol Sci. 2004;96(4):349-359. https://pubmed.ncbi.nlm.nih.gov/15599101
- Peretz A, Neve J, Duchateau J, Famaey JP. Adjuvant treatment of recent onset rheumatoid arthritis by selenium supplementation. Br J Rheumatol. 1992;31(4):281-282. https://pubmed.ncbi.nlm.nih.gov/1555031
- Oster O, Prellwitz W. Selenium and cardiovascular disease. Biol Trace Elem Res. 1990;24(2):91-103. https://pubmed.ncbi.nlm.nih.gov/1702671
- Vaddadi KS, Soosai E, Vaddadi G. Low blood selenium concentrations in schizophrenic patients on clozapine. Br J Clin Pharmacol. 2003;55(3):307-309. https://pubmed.ncbi.nlm.nih.gov/12630982
- Burk RF, Norsworthy BK, Hill KE, et al. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev. 2006;15(4):804-810. https://pubmed.ncbi.nlm.nih.gov/16614127
- Manzanares W, Lemieux M, Elke G, et al. High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis. Crit Care. 2016;20(1):356. https://pubmed.ncbi.nlm.nih.gov/27806723
- Kim JM, Stewart R, Kim SW, et al. Selenium and suicidal ideation. J Affect Disord. 2019;243:139-145. https://pubmed.ncbi.nlm.nih.gov/30243195
- Faghihi T, Radfar M, Barmal M, et al. A randomized, placebo-controlled trial of selenium supplementation in patients with type 2 diabetes. J Diabetes Metab Disord. 2014;13(1):15. https://pubmed.ncbi.nlm.nih.gov/24401170
- Letsiou S, Nomikos T, Panagiotakos D, et al. Serum total selenium status in Greek adults and its relation to age. Biol Trace Elem Res. 2009;128(1):8-17. https://pubmed.ncbi.nlm.nih.gov/18953504
- Eick SM, Meeker JD, Brown P, et al. Associations between prenatal maternal exposure to per- and polyfluoroalkyl substances and selenium. Environ Int. 2022;158:106934. https://pubmed.ncbi.nlm.nih.gov/34653860
- Fairweather-Tait SJ, Bao Y, Broadley MR, et al. Selenium in human health and disease. Antioxid Redox Signal. 2011;14(7):1337-1383. https://pubmed.ncbi.nlm.nih.gov/20812787
- Chen J. An original discovery: selenium deficiency and Keshan disease. Asia Pac J Clin Nutr. 2012;21(3):320-326. https://pubmed.ncbi.nlm.nih.gov/22705420
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686
- National Institutes of Health Office of Dietary Supplements. Selenium: fact sheet for health professionals. Updated 2021. https://ods.od.nih.gov/factsheets/Selenium-HealthProfessional/
- Tonelli M, Wiebe N, Hemmelgarn B, et al. Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med. 2009;7:25. https://pubmed.ncbi.nlm.nih.gov/19454005
- Rayman MP, Bath SC, Westaway J, et al. Selenium status in UK pregnant women and its relationship with hypertensive conditions of pregnancy. Br J Nutr. 2015;113(2):249-258. https://pubmed.ncbi.nlm.nih.gov/25571960